These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Efficacy, safety, and pharmaco-economical aspects of the therapy for dyslipidemia with brand-name and generic statins].
    Author: Ol'binskaia LI, Danilogorskaia IuA.
    Journal: Ter Arkh; 2003; 75(12):47-50. PubMed ID: 14959470.
    Abstract:
    AIM: To compare clinical, cost-effect efficacies and safety of simvastatin Zokor and generic Vasilip in correction of dislipoproteinemia in patients with ischemic heart disease. MATERIAL AND METHODS: The original statin Zokor and generic statin Vasilip were given for 8 weeks in a dose 20 mg/day. RESULTS: Vasilip and Zokor demonstrated similar hypolipidemic efficacy and safety, but Vasilip administration was more cost-effective. CONCLUSION: Simvastatin Vasilip is recommended for wider use in clinical practice because it is clinically and cost effective.
    [Abstract] [Full Text] [Related] [New Search]